RP-2011-24: Branded Prescription Drug Sales – Dispute Resolution Process for 2011 Preliminary Fee Calculation

Internal Revenue Service (IRS) sent this bulletin at 05/02/2011 02:15 PM EDT

Having trouble viewing this email? View it as a Web page.

IRS GuideWire

May 2, 2011

News Essentials

IRS Resources

Compliance & Enforcement

Contact My Local Office

e-file

Forms & Pubs

Frequently Asked Questions

News

Taxpayer Advocacy

Where to File

Issue Number: RP-2011-24

Inside This Issue

Revenue Procedure 2011-24 establishes a dispute resolution process for the preliminary fee calculation for the 2011 annual fee imposed on covered entities engaged in the business of manufacturing or importing branded prescription drugs. The revenue procedure provides guidance on what information needs to be submitted regarding an asserted error, in what format the information must be submitted, who may submit the information, the deadline for submitting the information, and an IRS contact person.

Revenue Procedure 2011-24 will be in IRB 2011-20, dated May 16, 2011.

Thank you for subscribing to IRS GuideWire, an IRS e-mail service. If you are a Tax Professional and have a specific concern about your tax situation, call the IRS Practitioner Priority Service 1-866-860-4259.

This message was distributed automatically from the IRS GuideWire mailing list. Please Do Not Reply To This Message.

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by the Internal Revenue Service (IRS).